19th Nov 2015 11:48
Ap27
FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISEDINTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | J.P. Morgan Securities LLC. |
Company dealt in | Pfizer Inc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | Common Stock |
Date of dealing | 18 November 2015 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)
Class of relevant security: | Long | Short | ||||
Common Stock | Number | (%) | Number | (%) | ||
(1) Relevant securities | 5,287,701 0.09 | 3,761,070 0.06 | ||||
(2) Derivatives (other than options) | 1,239,408 0.02 | 2,496,887 0.04 | ||||
(3) Options and agreements to purchase/sell | 5,567,470 0.09 | 2,404,500 0.04 | ||||
Total | 12,094,579 0.20 | 8,662,457 0.14
| ||||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)
Class of relevant security: | Long | Short | ||||
Number | (%) | Number | (%) | |||
(1) Relevant securities | ||||||
(2) Derivatives (other than options) | ||||||
(3) Options and agreements to purchase/sell | ||||||
Total | ||||||
Ap28
3. DEALINGS (Note 3)
(a) Purchases and sales
Purchases/ sales
| Number of relevant securities | Price per unit (USD) |
Purchases
Sales | 100 3 16,658 9,728 5,000 5,079 4,900 200 400 400 100 9,500 24 2,200 600 8,804 1,600 3,000 1,300 12,272 900 300 1,200 3,200 3,000 200 2,800 100 5,800
12,400 200 205 16,658 300 6 200 400 500 900 758 800 400 9,470 | 33.0350 33.0500 33.0536 33.3000 33.3062 33.3100 33.3122 33.3150 33.3300 33.3350 33.3400 33.3450 33.3500 33.3550 33.3600 33.3621 33.3681 33.3687 33.3700 33.3732 33.3750 33.3775 33.3850 33.3900 33.3950 33.4000 33.4050 33.4100 33.4150
33.0366 33.0400 33.0491 33.0536 33.0667 33.0700 33.0800 33.0825 33.0940 33.0967 33.1156 33.1200 33.1325 33.3100 |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 5) | Number of relevant securities (Note 6) | Price per unit (USD) (Note 4) |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 4) |
Call Option Put Option | Purchasing Purchasing | 41,100 50,000 | 34.00 33.00 | American American | 18/12/15 18/12/15 | 0.70 0.90 |
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 4) |
Leveraged Accumulator | 370 | 29.1203 |
+ bought by counterparty at exercise price
(d) Other dealings (including transactions in respect of new securities) (Note 3)
Nature of transaction (Note 7) | Details | Price per unit (if applicable) (Note 4) |
Ap29
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securitiesunder any option referred to on this form or relating to the voting rights or future acquisitionor disposal of any relevant securities to which any derivative referred to on this form is referenced.If none, this should be stated.
Is a Supplemental Form 38.5(b) attached? (Note 8) YES
Date of disclosure | 19 November 2015 |
Contact name | Tung Le |
Telephone number | 020 7742 7272 |
Name of offeree/offeror with which connected | Allergan plc |
Nature of connection (Note 9) | Adviser to Allergan plc |
SUPPLEMENTAL FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 38.5(b)) OPEN POSITIONS (Note 1)
Product name, e.g. call option | Written or purchased | Number of relevant securities to which the option or derivative relates | Exercise price (Note 2)(USD) | Type, e.g. American, European etc. | Expiry date |
Call option
| Purchased | 30,000 | 35.00 | American | 20/01/17 |
Call option | Purchased | 70,000 | 37.00 | American | 20/01/17 |
Call option | Purchased | 363,900 | 35.00 | American | 15/01/16 |
Call option | Purchased | 700 | 38.00 | American | 15/01/16 |
Call option | Purchased | 1,200,000 | 34.00 | American | 20/11/15 |
Call option | Written
| 2,500 | 28.00 | American | 15/01/16 |
Call option | Written | 14,700 | 30.00 | American | 15/01/16 |
Call option | Written | 200 | 37.00 | American | 15/01/16 |
Call option | Written | 150,000 | 37.00 | American | 15/01/16 |
Call option | Written | 50,000 | 33.00 | American | 18/12/15 |
Call option | Written | 6,000 | 34.00 | American | 18/12/15 |
Call option | Written | 7,600 | 32.00 | American | 15/01/16 |
Call option | Purchased | 383,200 | 34.71 | European | 21/12/15 |
Call option | Purchased | 383,200 | 34.71 | European | 21/12/15 |
Call option | Purchased | 127,794 | 35.28 | European | 03/12/15 |
Call option | Purchased | 120,533 | 35.66 | European | 12/01/16 |
Call option | Purchased | 48,943 | 36.47 | European | 25/01/16 |
Call option | Written | 200,000 | 33.00 | European | 16/12/16 |
Call option | Written | 383,200 | 34.71 | European | 21/12/15 |
Put option | Purchased
| 30,000 | 35.00 | American | 20/01/17 |
Put option | Purchased | 20,000 | 35.00 | American | 20/01/17 |
Put option | Purchased | 4,300 | 30.00 | American | 15/01/16 |
Put option | Purchased | 2,800 | 28.00 | American | 15/01/16 |
Put option | Purchased | 300 | 32.00 | American | 15/01/16 |
Put option | Purchased | 150,000 | 30.00 | American | 16/09/16 |
Put option | Purchased | 100,000 | 36.00 | American | 18/03/16 |
Put option | Purchased | 32,900 | 32.00 | American | 15/01/16 |
Put Option | Purchased | 1,000,000 | 33.50 | American | 20/11/15 |
Put option | Written | 9,200 | 33.00 | American | 19/02/16 |
Put option | Written | 19,100 | 31.00 | American | 19/02/16 |
Put option | Written | 5,300 | 23.00 | American | 15/01/16 |
Put option | Written | 100,000 | 30.00 | American | 15/01/16 |
Put option | Written | 5,600 | 25.00 | American | 15/01/16 |
Put option | Written | 250,000 | 28.00 | American | 15/01/16 |
Put Option | Written | 500,000 | 33.00 | American | 18/03/16 |
Put Option | Purchased | 200,000 | 33.00 | European | 16/12/16 |
Put Option | Written
| 117,900 | 35.00 | American | 17/06/16 |
Put Option | Written | 62,400 | 35.00 | American | 17/06/16 |
Put Option | Written | 71,300 | 35.00 | American | 17/06/16 |
Put Option | Written | 646,800 | 35.00 | American | 17/06/16 |
Put Option | Written | 154,500 | 35.00 | American | 17/06/16 |
Put Option | Written | 308,100 | 35.00 | American | 17/06/16 |
Put Option | Written
| 139,000 | 35.00 | American | 17/06/16 |
Put Option | Written
| 450,000 | 35.00 | American | 15/01/16 |
Callable Barrier Reverse Convertible Note | Purchased | 183,430 | 32.71 | N/A | 21/03/17 |
Callable Barrier Reverse Convertible Note | Purchased | 30,572 | 32.71 | N/A | 21/03/17 |
Auto-callable Barrier Reverse Convertible Note | Purchased | 45,984 | 32.62 | N/A | 17/03/17 |
Barrier Reverse Convertible Note | Purchased | 30,408 | 34.53 | N/A | 05/04/16 |
Equity Linked Note | Purchased | 6,740 | 29.67 | N/A | 03/02/16 |
Leveraged Accumulator | Purchased | 14,874 + | 29.12 | N/A | 12/09/16 |
Callable Barrier Reverse Convertible Note | Written | 183,430 | 32.71 | N/A | 21/03/17 |
Callable Barrier Reverse Convertible Note | Written | 30,572 | 32.71 | N/A | 21/03/17 |
Auto-Callable Barrier Reverse Convertible Note | Written | 45,984 | 32.62 | N/A | 17/03/17 |
Barrier Reverse Convertible Note | Written | 30,408 | 34.53 | N/A | 05/04/16 |
Equity Linked Note | Written | 6,740 | 29.67 | N/A | 03/02/16 |
Leveraged Accumulator | Written | 14,874 + | 29.12 | N/A | 12/09/16 |
Leveraged Accumulator | Written | 9,000+ | 31.70 | N/A | 04/03/16 |
Auto-callable Optimization Securities | Written | 7,851 | 27.60 | N/A | 25/06/20 |
Equity Linked Note | Written | 6,740 | 29.67 | N/A | 03/02/16 |
Callable Barrier Reverse Convertible Note | Written | 183,430 | 32.71 | N/A | 21/03/17 |
Callable Barrier Reverse Convertible Note | Written | 30,572 | 32.71 | N/A | 21/03/17 |
Auto-Callable Barrier Reverse Convertible Note | Written | 45,984 | 32.62 | N/A | 17/03/17 |
Barrier Reverse Convertible Note | Written | 30,408 | 34.53 | N/A | 05/04/16 |
Leveraged Accumulator | Written | 14,874 + | 29.12 | N/A | 12/09/16 |
Put Option | Purchased | 457,000 | 27.50 | N/A | 11/01/16 |
Callable Barrier Reverse Convertible | Purchased | 22,929 | 32.71 | N/A | 21/03/17 |
Auto-Callable Barrier Reverse Convertible Note | Purchased | 7,685 | 32.53 | N/A | 15/03/17 |
Auto-Callable Barrier Reverse Convertible Note | Purchased | 11,189 | 32.62 | N/A | 17/03/17 |
Barrier Reverse Convertible Note | Purchased | 178 | 2.44 | N/A | 05/04/16 |
Equity Link Note | Purchased | 31,133 | 32.12 | N/A | 15/12/15 |
Equity Link Note | Written | 31,133 | 32.12 | N/A | 15/12/15 |
Equity Link Note | Written | 31,133 | 32.12 | N/A | 15/12/15 |
Put Option | Purchased | 50,000 | 33.00 | American | 18/12/15 |
+ This instrument is physically settled, and the interest in shares has been calculated as the maximum number of Mylan shares that the counterparty could be obliged to buy at the exercise price
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given.Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rules 8 and 38.5 of the Rules. If in doubt, consult the Panel.
Related Shares:
PFZ.L